United States

September 29, 2022

FDA approves ALS treatment despite questions about efficacy

The drug is safe, and one study found it may prolong survival and slow paralysis in functions like muscle control and speech. A larger trial will be completed in 2024. Source link
September 29, 2022

FDA approves ALS treatment despite questions about efficacy

The drug is safe, and one study found it may prolong survival and slow paralysis in functions like muscle control and speech. A larger trial will be completed in 2024. Source link
September 29, 2022

Physician burnout has reached worrying levels, new research shows

Nearly two-thirds of doctors experience at least one burnout symptom, a huge increase from before the pandemic. But the situation is not irreparable, researchers say. Source link
gdpr-image
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more